Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge

Vaccine

Volumn 20, Issue 17-18, 2002, Pages 2382-2395

  Sykes, Kathryn F ^a,c   Lewis, Mark G ^b   Squires, Burke ^a   Johnston, Stephen Albert ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c Eliance Biotechnology Inc   (United States)

Author keywords

ELI; Genetic adjuvants; SIV trial

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EVALUATION; GENE EXPRESSION; GENE LIBRARY; GENETIC CODE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MACACA; MONKEY; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL RATE; VACCINATION; VIRUS LOAD;

ANIMALS; DNA, VIRAL; GENE LIBRARY; GENETIC ENGINEERING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-12; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 0037157261     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00094-4     Document Type: Article

References (51)

1. HIV - AIDS now world's fourth biggest killer
2. Current progress in the development of human immunodeficiency virus vaccines: Research and clinical trials
3. The moving target: Mechanisms of HIV persistence during primary infection
4. Is an HIV vaccine possible?
5. HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells
6. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention
7. Towards an HIV-1 vaccine - Lessons from studies in macaque models
8. Candidate vaccines protect macaques against primate immunodeficiency viruses
9. Simian immunodeficiency virus DNA vaccine trial in macaques
10. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
11. Progress in the development of an HIV-1 vaccine
12. Challenges and opportunities for development of an AIDS vaccine
13. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
14. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants
15. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments]
16. Protection effect of a live-attenuated SIV vaccine with deletion in nef gene
17. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus
18. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques [see comments]
19. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [see comments] [published erratum appears in Nat Med 1994;5(5):590]
20. Attenuated HIV vaccine: Caveats [letter; Comment]
21. Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus
22. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
23. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
24. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
25. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation
26. Protection against mycoplasma infection using expression-library immunization
27. Expression library immunization to identify protective antigens from Cowdria ruminantium
28. Protection against murine cysticercosis using cDNA expression library immunization
29. Specific cellular and humoral immune response in balb/c mice immunised with an expression genomic library of trypanosoma cruzi
30. Expression library immunization protects mice against a challenge with virulent rodent malaria
31. Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses
32. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme
33. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
34. Titration and characterization of two rhesus-derived SIVmac challenge stocks
35. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
36. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys
37. An African primate lentivirus (SIVsm) closely related to HIV-2
38. Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I study
39. Simian immunodeficiency virus DNA vaccine trial in macaques
40. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression
41. Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
42. The role of nonhuman primate models in AIDS vaccine development
43. Biological features of genetic immunization
44. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
45. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
46. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
47. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
48. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
49. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/IG administration
50. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1
51. Protection against mycoplasma infection using expression-library immunization